James Loerop Net Worth

The estimated Net Worth of James E Deerfield Mgmt L.P.... is at least 11.5 百万$ dollars as of 27 June 2019. Mr P owns over 699,475 units of Aclaris Therapeutics Inc stock worth over 3,727,815$ and over the last 6 years he sold ACRS stock worth over 7,742,486$.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Loerop ACRS stock SEC Form 4 insiders trading

Mr has made over 5 trades of the Aclaris Therapeutics Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 699,475 units of ACRS stock worth 1,881,588$ on 27 June 2019.

The largest trade he's ever made was buying 843,352 units of Aclaris Therapeutics Inc stock on 29 May 2018 worth over 15,998,387$. On average, Mr trades about 290,389 units every 44 days since 2018. As of 27 June 2019 he still owns at least 3,159,165 units of Aclaris Therapeutics Inc stock.

You can see the complete history of Mr P stock trades at the bottom of the page.

Mr. James Loerop biography

James Loerop is the Chief Bus. Officer at Aclaris Therapeutics Inc.

How old is Mr Loerop?

Mr Loerop is 56, he's been the Chief Bus. Officer of Aclaris Therapeutics Inc since . There are 3 older and 10 younger executives at Aclaris Therapeutics Inc. The oldest executive at Aclaris Therapeutics Inc is Maxine Gowen, 62, who is the Independent Director.

What's Mr Loerop's mailing address?

James's mailing address filed with the SEC is 780 3rd Ave, New York, NY 10017, USA.

Insiders trading at Aclaris Therapeutics Inc

Over the last 9 years, insiders at Aclaris Therapeutics Inc have traded over 101,608,525$ worth of Aclaris Therapeutics Inc stock and bought 10,163,038 units worth 66,383,599$ . The most active insiders traders include Braden Michael Leonard、Capital Management, Llc Kol...、Llc Fmr. On average, Aclaris Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of 111,818$. The most recent stock trade was executed by Kevin Balthaser on 1 September 2024, trading 1,000 units of ACRS stock currently worth 1,180$.

What does Aclaris Therapeutics Inc do?

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.

Complete history of Mr P stock trades at Aclaris Therapeutics Inc、Kiniksa Pharmaceuticals International Plc

Aclaris Therapeutics Inc executives and stock owners

Aclaris Therapeutics Inc executives and other stock owners filed with the SEC include:

• Neal Walker,
  President, Chief Executive Officer, Co-Founder, Director
• Kamil Ali-Jackson,
  Co-Founder, Chief Compliance Officer, Secretary, Chief Legal Officer
• David Gordon,
  Chief Medical Officer
• Frank Ruffo,
  Co-Founder, Chief Financial Officer
• Dr. Neal S. Walker D.O.,
  Co-Founder, CEO, Pres & Director
• Frank Ruffo,
  Co-Founder, CFO & Treasurer
• Christopher Molineaux,
  Independent Director
• Bryan Reasons,
  Independent Director
• Andrew Powell,
  Independent Director
• Anand Mehra,
  Independent Director
• William Humphries,
  Independent Director
• Andrew Schiff,
  Independent Director
• Maxine Gowen,
  Independent Director
• Vincent Milano,
  Director
• James Loerop,
  Chief Bus. Officer
• Dr. Paul S. Changelian Ph.D.,
  Sr. VP of Biology
• Spencer Brown J.D.,
  Sr. VP of Legal Affairs & Compliance Officer
• Dr. Joseph Monahan,
  Chief Scientific Officer
• Rick Bierly,
  Director
• Ventures Vii, Llc Vivo Vent...,
  
• Stephen A. Tullman,
  Director
• Albert Cha,
  Director
• Stuart Shanler,
  Chief Scientific Officer
• Capital Management, Llc Kol...,
  
• Christopher Powala,
  Chief Operating Officer
• Llc Fmr,
  10% owner
• James E Deerfield Mgmt L.P....,
  
• Capital Management Iii, Llc...,
  
• Brett Fair,
  Chief Commercial Officer
• Capital Management, Llc Kol...,
  
• Venture Partners Viii, L.P....,
  
• Gail Cawkwell,
  Chief Medical Officer
• Joseph Monahan,
  Chief Scientific Officer
• Douglas J. Manion,
  Pres and CEO
• James Loerop,
  Chief Business Officer
• Braden Michael Leonard,
  
• Kevin Balthaser,
  Chief Financial Officer